Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.87
13.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Zhejiang Xianju Pharmaceutical Co Ltd
Income to Minority Interest
Zhejiang Xianju Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
|
Income to Minority Interest
-¥7.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income to Minority Interest
-¥34.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-61%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income to Minority Interest
¥5.1m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income to Minority Interest
-¥31.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zhejiang Xianju Pharmaceutical Co Ltd
Glance View
Zhejiang Xianju Pharmaceutical Co., Ltd. engages in the manufacture and sale of steroid and hormone drugs. The company is headquartered in Taizhou, Zhejiang and currently employs 3,656 full-time employees. The company went IPO on 2010-01-12. is a China-based company principally engaged in the research, manufacture and distribution of steroid active pharmaceutical ingredients (APIs) and preparations. The firm's products are mainly categorized into cortex hormone drugs, gynecology and family planning drugs, as well as anesthesia drugs and muscle relaxants. The firm is also involved in the provision of respiratory drugs, immunomodulators, dermatology drugs, anaesthetic drugs and others. The firm distributes its products in domestic market and to overseas markets.
See Also
What is Zhejiang Xianju Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
-7.8m
CNY
Based on the financial report for Jun 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Income to Minority Interest amounts to -7.8m CNY.
What is Zhejiang Xianju Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
33%
Over the last year, the Income to Minority Interest growth was -71%. The average annual Income to Minority Interest growth rates for Zhejiang Xianju Pharmaceutical Co Ltd have been 22% over the past three years , 33% over the past five years .
You don't have any saved screeners yet
